Live Breaking News & Updates on Geboes Index

Stay updated with breaking news from Geboes index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

Etrasimod was effective and well tolerated as an induction and maintenance therapy
in patients with moderately to severely active ulcerative colitis. Etrasimod is a
treatment option with a unique combination of attributes that might address the persistent
unmet needs of patients with ulcerative colitis. ....

United States , Western University , San Francisco , Cytoki Pharma , Eli Lilly , Exeliom Biosciences , Vivreon Gastrosciences , Ventyx Biosciences , Oppilan Pharma , Tillotts Pharma , Viela Bio , Falk Pharma , Samantha Odwyer , Fresenius Kabi , Zealand Pharma , Galen Atlantica , Theravance Biopharma , Miro Bio , Vimalan Biosciences , Genentech Roche , Pharm Olam , Trellus Health , Boehringer Ingelheim , Ironwood Pharmaceuticals , Thermo Fisher , Health Interactions San Francisco ,

VARSITY: Better Outcomes With Vedolizumab Than Adalimumab in UC

VARSITY: Better Outcomes With Vedolizumab Than Adalimumab in UC
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Laurent Peyrin Biroulet , Nancy France University Hospital , Pp Colitis Organisation , University Hospital , Geboes Index , Robarts Histopathology Index ,